Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer. Racz B, Kristof E, Kincses A, Dominguez-Alvarez E, et al. Anticancer Res 2023;43:4865-4872.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Racz B, Kristof E, Kincses A, Dominguez-Alvarez E, et al. Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer. Anticancer Res 2023;43:4865-4872.
PMID: 37909996